Impact of Cost Control Policies for Drug and Medical Supplies Expenditure: Case Study of Wetchakarunrasm Hospital

Main Article Content

Khobsoh Hasamoh
Nilawan Upakdee

Abstract

Introduction: Due to the continued increase in drug and medical supplies expenditure, drug and medical supplies control policies have been implemented since the fiscal year 2017 at Wetchakarunrasm hospital. The cost control policies covered three domains including 1) price control policy; 2) quantity control policy; and 3) quantity and price control policy. This descriptive study aimed to assess the impact of cost control policies on drug and medical supplies expenditure. Methods: Drug and medical supplies expenditure during one year before (1 October 2015 – 30 September 2016) and one year after (1 October 2016 - 30 September 2017) implementation of cost control policies were explored. Changes in total drug and medical supplies expenditure were identified. Results: Implementation of drug and medical supplies control policies resulted in reducing drug expenditure by 15,015,951.75 bath (11.62 percent) and reducing medical supplies expenditure by 864,627.41 bath (17.51 percent). The top three drug control measures that highly potential to reduce the drug expenditure including negative list of non- essential drug (NED) and therapeutic substitution by essential drug (ED) and non-essential drug (NED) (reducing drug cost by 2,739,047.75 bath, 40.71 percent), limiting duplicate drug lists (reducing drug cost by 1,862,006.50 bath, 71.68 percent) and purchasing generic drugs with lower price ( reducing drug cost by 456,966 bath, 5.12 percent), respectively. Conclusion: The drug and medical supplies control policies help to reduce hospital expenditure.

Downloads

Download data is not yet available.

Article Details

Section
Pharmaceutical Practice

References

Andersson K, Bergstrom G, Petzold M, Carlsten A. Impact of generic substitution reform on patient’s and society’s expenditure for pharmaceuticals. Health Policy. 2007;81:376-84

Chaiyasong S, Chaiyasong C. Impacts of esomeprazole injection use control policy on drug utilization and expenditures in Mahasarakham hospital. IJPS 2014;10(2):161-72

Chandra H, Naik AK. Cost awareness and containment : OPD pharmaceutical services of a specialty hospital. JK Science. 2005;7(1):1-3

Haichai T, Upakdee N. Preparation of royal Thai air force hospitals towards the generic drug pricing policy for civil servant medical benefit scheme. Journal of health science 2016;25(6):1040-48

Hathaidumrongwittaya M, Upakdee N. Assessment of the impact of policies to control the cost of drug and medical supplies at Tharuea hospital,Phra nakorn sri ayuttaya province. HCU journal of health science 2017;20(40)77-86

Health Information System Development Office. Health expenses2010[online]. [cite 2017 Aug 20]. Available from: http://www.hiso.or.th/hiso5/report/download.php?name=thai2009_6

Health insurance system research office. Lesson learned report measures for promoting rational use of drug in the master hospital2012 [In Thai]. Nonthaburi. The Comptroller General’s Department.

Health insurance system research office. Report the results of the development of data collection system monitor drug orders and provide feedback to the hospital July 2011-March 2012 [In Thai]. Nonthaburi. The Comptroller General’s Department.

Health systems research institute. The Universal Health Care Coverage Assessment Report for the First Decade (2001-2010) [In Thai]. Nonthaburi.

International health policy program. Ministry of Public Health.National Health Accounts of Thailand 2009-2010.[cite 2018 Feb 25]. Available from: http://hpc4.go.th/director/data/p4p/Final_Report_Thai-NHA_2009-2010_final_June2012.pdf

Limwattananon C, Sooksai N, Topark-Ngarm A, Waleekhachonloet O, Kitwiti P, Rattanachotphanit T, et al. Measures to promote rational use of medicine in public hospitals: a review and analysis of national policy interventions. Journal of health systems research 2013;7(1):33-44

Limwattananon C, Thammatacharee N, Waleekhachonloet O, Thamwanna P, Limwattananon S, Srithamrongsawat S. Expenditure of civil servant medical benefit scheme and the use of non-essential medicines. Journal of health systems research 2011;5(2):149-59

Limwattananon S, Limwattananon C, Cheawchanwattana A et al. Forecasted expenditure due to the use of expensive drugs in civil servant medical benefit scheme: a comparison with universal health coverage scheme. Journal of health systems research 2011;5(2):170-180

Moolasarn S, Watcharathanakit S, Buasi N, Sutthipornchai M, Muensook N, Kongsuk T. Prescribing of original brand name drugs and opinion of physicians on strategies to reduce its prescription. Journal of health science 2013;22(2):307-17

Pacey S, Warner J, Li wan Po A. A multidisciplinary approach to hospital-based drug cost containment. Journal of Clinical Pharmacy and Therapeutics. 1998;23:203-11.

Simoens S, Coster S. Sustaining generic medicines markets in Europe. Journal of Generic Medicines. 2006;3:257-68

Sooksrivong C. Drug prices in Thailand 2013 [online]. [cited 2017 Aug 11]. Available from: http://www.pharmacy.mahidol.ac.th/th/knowledge/article/166/

Suanrueang P, Topark-ngarm A, Sakolchai S, Limwattananon C, Suriyawongpaisal P, Srithamrongsawat S. Measures for promoting rational use of high cost drugs in hospitals under Civil Servant Medical Benefit Scheme. Journal of health systems research 2013;7(2):223-34.

Thummavut V, Leuvittawat P. Survey on the amount and value of drugs in outpatients, Department of Internal Medicine, Siriraj Hospital. Siriraj medical bulletin 2014;7(1):20-25.

Upakdee N, Pansang S. Responsiveness to glucosamine negative list policy of civil servant medical benefit scheme. Journal of health systems research 2014;8(3):230-37.

Wetchakarunrasm hospital annual report 2013. Wetchakarunrasm hospital, Medical service department, Bangkok metropolitan administration.

Wetchakarunrasm hospital annual report 2014. Wetchakarunrasm hospital, Medical service department, Bangkok metropolitan administration.

Wetchakarunrasm hospital annual report 2015. Wetchakarunrasm hospital, Medical service department, Bangkok metropolitan administration.

Yingseree B. Outpatient drug cost containment in civil servant medical benefit scheme: lessons from Lampang hospital. Journal of health science 2012;21(5):972-85.